Literature DB >> 30558827

Interstitial Lung Disease and Other Pulmonary Manifestations in Connective Tissue Diseases.

Isabel Mira-Avendano1, Andy Abril2, Charles D Burger3, Paul F Dellaripa4, Aryeh Fischer5, Michael B Gotway6, Augustine S Lee3, Joyce S Lee5, Eric L Matteson7, Eunhee S Yi8, Jay H Ryu9.   

Abstract

Lung involvement in connective tissue diseases is associated with substantial morbidity and mortality, most commonly in the form of interstitial lung disease, and can occur in any of these disorders. Patterns of interstitial lung disease in patients with connective tissue disease are similar to those seen in idiopathic interstitial pneumonias, such as idiopathic pulmonary fibrosis. It may be difficult to distinguish between the 2 ailments, particularly when interstitial lung disease presents before extrapulmonary manifestations of the underlying connective tissue disease. There are important clinical implications in achieving this distinction. Given the complexities inherent in the management of these patients, a multidisciplinary evaluation is needed to optimize the diagnostic process and management strategies. The aim of this article was to summarize an approach to diagnosis and management based on the opinion of experts on this topic.
Copyright © 2018. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2018        PMID: 30558827     DOI: 10.1016/j.mayocp.2018.09.002

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  18 in total

1.  Assessment of interstitial lung disease among black rheumatoid arthritis patients.

Authors:  Isabel M McFarlane; Su Yien Zhaz; Manjeet S Bhamra; Aaliya Burza; Srinivas Kolla; Milena Rodriguez Alvarez; Kristaq Koci; Nicholas Taklalsingh; Joshy Pathiparampil; Latoya Freeman; Ian Kaplan; Naureen Kabani; David J Ozeri; Elsie Watler; Mosab Frefer; Vytas Vaitkus; Keron Matthew; Fray Arroyo-Mercado; Helen Lyo; Tomasz Zrodlowski; Aleksander Feoktistov; Randolph Sanchez; Cristina Sorrento; Faisal Soliman; Felix Reyes Valdez; Veena Dronamraju; Michael Trevisonno; Christon Grant; Guerrier Clerger; Khabbab Amin; Makeda Dawkins; Jason Green; Jane Moon; Samir Fahmy; Stephen Anthony Waite
Journal:  Clin Rheumatol       Date:  2019-08-30       Impact factor: 2.980

2.  Interstitial Lung Disease Associated with Connective Tissue Diseases.

Authors:  Ruben A Peredo; Vivek Mehta; Scott Beegle
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 3.  Demystifying idiopathic interstitial pneumonia: time for more etiology-focused nomenclature in interstitial lung disease.

Authors:  Nevins W Todd; Sergei P Atamas; Stella E Hines; Irina G Luzina; Nirav G Shah; Edward J Britt; Andrew J Ghio; Jeffrey R Galvin
Journal:  Expert Rev Respir Med       Date:  2022-01-31       Impact factor: 3.772

4.  Evaluation of connective tissue disease-related interstitial lung disease using ultrasound elastography: a preliminary study.

Authors:  Songya Huang; Ruiqian Guo; Xinhui Yuan; Xinyi Tang; Tao Liu; Qibing Xie; Li Qiu
Journal:  Quant Imaging Med Surg       Date:  2022-07

Review 5.  Clinical and radiological features of lung disorders related to connective-tissue diseases: a pictorial essay.

Authors:  Stefano Palmucci; Federica Galioto; Giulia Fazio; Agata Ferlito; Giovanna Cancemi; Alessia Di Mari; Gianluca Sambataro; Domenico Sambataro; Giovanni Zanframundo; Letizia Antonella Mauro; Pietro Valerio Foti; Carlo Vancheri; Antonio Basile
Journal:  Insights Imaging       Date:  2022-06-29

6.  Clinical characteristics of interstitial lung diseases positive to different anti-synthetase antibodies.

Authors:  Minna Jiang; Xin Dong; Yi Zheng
Journal:  Medicine (Baltimore)       Date:  2021-05-14       Impact factor: 1.889

7.  Management of Patients with Connective Tissue Disease-associated Interstitial Lung Diseases During the COVID-19 Pandemic.

Authors:  Canan Gunduz Gurkan; Dilek Karadogan; Furkan Ufuk; Osman Cure; Goksel Altinisik
Journal:  Turk Thorac J       Date:  2021-07

8.  Efficacy and Safety of Tripterygium Wilfordii Hook. F for Connective Tissue Disease-Associated Interstitial Lung Disease:A Systematic Review and Meta-Analysis.

Authors:  Yehui Li; Wen Zhu; Hailang He; Yordan Angelov Garov; Le Bai; Li Zhang; Jing Wang; Jinghai Wang; Xianmei Zhou
Journal:  Front Pharmacol       Date:  2021-06-10       Impact factor: 5.810

9.  Comparative analysis of connective tissue disease-associated interstitial lung disease and interstitial pneumonia with autoimmune features.

Authors:  Mengxue Tian; Wenhan Huang; Feifeng Ren; Lei Luo; Jun Zhou; Dongmei Huang; Lin Tang
Journal:  Clin Rheumatol       Date:  2019-11-22       Impact factor: 2.980

Review 10.  Interstitial Lung Disease in Connective Tissue Disease: A Common Lesion With Heterogeneous Mechanisms and Treatment Considerations.

Authors:  Tihong Shao; Xiaodong Shi; Shanpeng Yang; Wei Zhang; Xiaohu Li; Jingwei Shu; Shehabaldin Alqalyoobi; Amir A Zeki; Patrick S Leung; Zongwen Shuai
Journal:  Front Immunol       Date:  2021-06-07       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.